Introduction of Levera RTU 500 Infusion:
Levera RTU 500 Infusion is an antiepileptic medication used to treat seizures (fits) in epilepsy. It can be used alone or in combination with other medications. It helps prevent seizures for as long as you continue to take it.
Levera RTU 500 Infusion is administered as an infusion (slow drip) into a vein under the supervision of a healthcare professional. It is typically used for short-term control of seizures when treatment with oral medication is not feasible (e.g., when the patient is unconscious). You should continue taking it for as long as your doctor has instructed you to, even if you feel well. Stopping or missing doses could worsen your seizures. Your doctor is likely to prescribe oral medications for long-term seizure control after treatment with this infusion has been completed.
Uses of Levera RTU 500 Infusion:
Treatment of Epilepsy/Seizures
Benefits of Levera RTU 500 Infusion:
In Treatment of Epilepsy/Seizures:
Levera RTU 500 Infusion belongs to a group of medications called anticonvulsants (or antiepileptics). It works by slowing down electrical signals in the brain that cause seizures (fits). This medication can be used to control various types of seizures myoclonic, partial onset, and primary generalized tonic-clonic (or grand mal). It can also help reduce symptoms like confusion, uncontrolled jerking movements, loss of awareness, and fear or anxiety. The medication can enable you to engage in some activities that you would otherwise be prohibited or afraid to do (like swimming and driving). It may take a few weeks for this medication to work (because the dose must be increased slowly), and during this time, you may still experience seizures. You should continue taking it even if you feel well and are not having any seizures. Missing doses may trigger a seizure. Do not stop using this medication until your doctor advises you to.
Mechanism of Action of Levera RTU 500 Infusion:
Levera RTU 500 Infusion is an antiepileptic drug that works by attaching to specific sites (SV2A) on the surfaces of nerve cells. This suppresses the abnormal activity of the nerve cells in the brain and prevents the spread of electrical signals that cause seizures.